Sumitomo Pharma Co., Ltd.

OTCPK:DNPU.F Stock Report

Market Cap: US$1.6b

Sumitomo Pharma Future Growth

Future criteria checks 3/6

Sumitomo Pharma is forecast to grow earnings and revenue by 89.5% and 4.1% per annum respectively. EPS is expected to grow by 89.5% per annum. Return on equity is forecast to be 3.9% in 3 years.

Key information

89.5%

Earnings growth rate

89.5%

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth rate4.1%
Future return on equity3.9%
Analyst coverage

Good

Last updated21 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:DNPU.F - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027362,5315,47312,26731,4668
3/31/2026361,69011,47412,96733,6318
3/31/2025344,494-9,08786,98421,3238
9/30/2024342,665-279,457-78,396-62,844N/A
6/30/2024329,547-260,167-151,893-136,785N/A
3/31/2024314,558-314,969-257,623-241,893N/A
12/31/2023330,307-173,718-289,603-275,326N/A
9/30/2023388,897-134,970-195,585-192,040N/A
6/30/2023471,354-144,485-132,356-131,413N/A
3/31/2023555,544-74,51211,31011,937N/A
12/31/2022588,228-8,44878,66578,709N/A
9/30/2022585,59412,68077,51088,927N/A
6/30/2022588,71582,71962,73577,233N/A
3/31/2022560,03556,41317,74531,239N/A
12/31/2021553,26232,32123,68036,782N/A
9/30/2021548,18455,37267,80681,324N/A
6/30/2021513,29142,76290,302102,279N/A
3/31/2021515,95256,219124,795135,601N/A
12/31/2020520,47767,031105,325117,235N/A
9/30/2020513,62747,72030,43940,420N/A
6/30/2020499,10552,30926,39938,398N/A
3/31/2020482,73240,75332,77746,128N/A
12/31/2019469,41352,63754,09166,333N/A
9/30/2019463,71551,08859,84473,527N/A
6/30/2019460,84040,08352,58465,450N/A
3/31/2019459,26748,62735,79748,711N/A
12/31/2018449,58842,826N/AN/AN/A
9/30/2018452,53046,43038,41455,607N/A
6/30/2018466,45254,285N/AN/AN/A
3/31/2018466,83853,448N/A93,420N/A
12/31/2017470,25250,011N/AN/AN/A
9/30/2017454,01352,956N/A52,872N/A
6/30/2017424,44735,035N/AN/AN/A
3/31/2017411,63828,991N/A21,624N/A
12/31/2016404,18130,923N/AN/AN/A
9/30/2016402,36822,405N/A48,663N/A
6/30/2016408,56627,122N/AN/AN/A
3/31/2016403,20624,697N/A49,415N/A
12/31/2015396,76319,799N/AN/AN/A
9/30/2015392,00616,903N/A22,963N/A
6/30/2015379,75515,632N/AN/AN/A
3/31/2015371,37015,447N/A30,251N/A
12/31/2014382,31719,896N/AN/AN/A
9/30/2014384,58723,122N/A49,243N/A
6/30/2014387,81421,007N/AN/AN/A
3/31/2014387,69320,061N/A49,943N/A
12/31/2013363,00312,334N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DNPU.F is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: DNPU.F is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: DNPU.F is expected to become profitable in the next 3 years.

Revenue vs Market: DNPU.F's revenue (4.1% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: DNPU.F's revenue (4.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DNPU.F's Return on Equity is forecast to be low in 3 years time (3.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y